Clinical Need

Cataracts are a loss of vision due to lens clouding.

If left untreated, cataracts can lead to blindness.

Current treatment options have limitations with visual side effects: glares, halos and artifacts.

Currently no solution mimics the natural ability of the eye to provide a full range of vision, from distance to near.


Atia Vision Modular Presbyopia Correcting Intraocular Lens (IOL)

Designed for true accommodation, aiming to restore the full range of vision

See How It Works

Watch the video to learn more about the Atia Vision Modular Presbyopia Correcting IOL

Watch the Video >


Atia Vision is a portfolio company of Shifamed, LLC, a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives.

The team at Atia Vision is committed to improving patient outcomes by developing a safe and controllable presbyopia correcting IOL that aims to restore the full range of functional vision in cataract patients, the largest segment of the ophthalmology market.3

Management Team

Mariam Maghribi

President & CEO

David Voris

Chief Financial Officer

Debbie White

Senior Vice President, Human Resources

Robert Edesess

Vice President, Intellectual Property

Melissa Guerrero

Senior Director of Quality Assurance